thromboxanes has been researched along with Psychotic Disorders in 1 studies
*Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, AC; Gattaz, WF; Joaquim, HPG; Loch, AA; Pereira, CAC; Talib, LL; van de Bilt, MT | 1 |
1 other study(ies) available for thromboxanes and Psychotic Disorders
| Article | Year |
|---|---|
COX-2 pathway is upregulated in ultra-high risk individuals for psychosis.
Topics: Cyclooxygenase 2; Humans; Prostaglandins; Prostaglandins E; Psychiatric Status Rating Scales; Psychotic Disorders; Thromboxanes | 2022 |